wambaugh2019.tox21: Tox21 2015 Active Hit Calls (EPA)

wambaugh2019.tox21R Documentation

Tox21 2015 Active Hit Calls (EPA)

Description

The ToxCast and Tox21 research programs employ batteries of high-throughput assays to assess chemical bioactivity in vitro. Not every chemical is tested through every assay. Most assays are conducted in concentration response, and each corresponding assay endpoint is analyzed statistically to determine if there is a concentration-dependent response or "hit" using the ToxCast Pipeline. Most assay endpoint-chemical combinations are non-responsive. Here, only the hits are treated as potential indicators of bioactivity. This bioactivity does not have a direct toxicological interpretation. The October 2015 release (invitrodb_v2) of the ToxCast and Tox21 data were used for this analysis. This object contains just the chemicals in Wambaugh et al. (2019) and only the quantiles across all assays for the ACC.

Usage

wambaugh2019.tox21

Format

A data.table with 401 rows and 6 columns

Author(s)

John Wambaugh

Source

ftp://newftp.epa.gov/COMPTOX/High_Throughput_Screening_Data/Previous_Data/ToxCast_Data_Release_Oct_2015/

References

Kavlock, Robert, et al. "Update on EPA's ToxCast program: providing high-throughput decision support tools for chemical risk management." Chemical research in toxicology 25.7 (2012): 1287-1302.

Tice, Raymond R., et al. "Improving the human hazard characterization of chemicals: a Tox21 update." Environmental health perspectives 121.7 (2013): 756-765.

Richard, Ann M., et al. "ToxCast chemical landscape: paving the road to 21st century toxicology." Chemical research in toxicology 29.8 (2016): 1225-1251.

Filer, Dayne L., et al. "tcpl: the ToxCast pipeline for high-throughput screening data." Bioinformatics 33.4 (2016): 618-620.

Wambaugh, John F., et al. "Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization." Toxicological Sciences 172.2 (2019): 235-251.


httk documentation built on March 7, 2023, 7:26 p.m.